Xsensio SA Raises $7M Oversubscribed Series A, Accelerates Clinical Deployment of Continuous Biosensing
PR Newswire —
LAUSANNE, Switzerland, March 3, 2026 /PRNewswire/ -- Xsensio SA, a Swiss deep-tech company pioneering near real-time continuous biochemical monitoring, today announced the successful closing of a $7M oversubscribed Series A financing round. The round was led by San Francisco-based venture...